People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology, Other, Pharmaceuticals, Medical Devices, Media & Content
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immunocore Holdings plc | — | Biotechnology | Series D+ | $140.0M | $2.9B | 2022 |
| Primetime Holdings Inc. | — | Other | Series B | $36.0M | $305.4M | 2023 |
| Cure Pharmaceutical Holding Corp. | — | Pharmaceuticals | Series B | $31.5M | $343.2M | 2020 |
| Gestalt Diagnostics, LLC | — | Medical Devices | Series A | $9.6M | $25.2M | 2019 |
| Cultivate Music, Inc. | — | Media & Content | Pre-Seed | $351K | $7.3M | 2019 |
John Bell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Bell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Herrick Lau | 1 | 10 |
| Steve Rector | 1 | 8 |
| David Berman | 1 | 8 |
| Wayne Wager | 1 | 6 |
| Gene Salkind | 1 | 5 |
| Alex Katz | 1 | 5 |
| Queenie Kuang | 1 | 4 |
| DAVID EATON | 1 | 4 |
| Kristine Peterson | 1 | 3 |
| CHARLES BERMAN | 1 | 3 |
| Kevin Mahoney | 1 | 3 |
| Robert Perez | 1 | 3 |
| Robert Davidson | 1 | 3 |
| Octavio Morales | 1 | 3 |
| Bahija Jallal | 1 | 3 |
| Bill Driscoll | 1 | 2 |
| Mark Udell | 1 | 2 |
| Edward Maliski | 1 | 2 |
| Travis Coy | 1 | 2 |
| Dan Roark | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.